We chart a right-first-time regulatory path by aligning your data with FDA, EMA, and DCGI expectations. Through gap analysis, TPP alignment, and study sequencing, we ensure every experiment maps cleanly to your IND/IMPD dossier. Our guidance anticipates reviewer queries and prevents costly repeats.